HomeCompareNUAG vs JNJ

NUAG vs JNJ: Dividend Comparison 2026

NUAG yields 4.44% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NUAG wins by $6.7K in total portfolio value
10 years
NUAG
NUAG
● Live price
4.44%
Share price
$20.94
Annual div
$0.93
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.7K
Annual income
$589.59
Full NUAG calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NUAG vs JNJ

📍 NUAG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUAGJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUAG + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUAG pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUAG
Annual income on $10K today (after 15% tax)
$377.11/yr
After 10yr DRIP, annual income (after tax)
$501.15/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $202.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUAG + JNJ for your $10,000?

NUAG: 50%JNJ: 50%
100% JNJ50/50100% NUAG
Portfolio after 10yr
$23.4K
Annual income
$708.69/yr
Blended yield
3.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NUAG
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUAG buys
0
JNJ buys
0
No recent congressional trades found for NUAG or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUAGJNJ
Forward yield4.44%3.36%
Annual dividend / share$0.93$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.7K$20.0K
Annual income after 10y$589.59$827.78
Total dividends collected$5.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NUAG vs JNJ ($10,000, DRIP)

YearNUAG PortfolioNUAG Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,144$443.66$10,676$355.77+$468.00NUAG
2$12,386$462.05$11,407$389.39+$979.00NUAG
3$13,733$479.96$12,198$426.53+$1.5KNUAG
4$15,191$497.34$13,056$467.62+$2.1KNUAG
5$16,769$514.18$13,987$513.12+$2.8KNUAG
6$18,473$530.44$14,998$563.56+$3.5KNUAG
7$20,312$546.12$16,098$619.52+$4.2KNUAG
8$22,296$561.21$17,295$681.69+$5.0KNUAG
9$24,432$575.70$18,599$750.82+$5.8KNUAG
10$26,732$589.59$20,022$827.78+$6.7KNUAG

NUAG vs JNJ: Complete Analysis 2026

NUAGStock

The Fund offers the potential for enhanced yield with the risk and credit quality profile of the broad U.S. investment-grade bond market. Rather than weighting by market cap, the strategy uses a rules-based methodology that allocates higher weights to securities and sectors that have the potential for higher yield, while maintaining comparable risk. The Fund invests primarily in U.S. government securities, debt securities issued by U.S. corporations, residential and commercial mortgage-backed securities, asset-based securities and U.S. dollar-denominated debt securities issued by non-U.S. governments and corporations. The Fund seeks to track the investment results, before fees and expenses, of the ICE BofA Enhanced Yield U.S. Broad Bond Index.

Full NUAG Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NUAG vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUAG vs SCHDNUAG vs JEPINUAG vs ONUAG vs KONUAG vs MAINNUAG vs ABBVNUAG vs MRKNUAG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.